FIVE PRIME THERAPEUTICS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$243.4M

744 transactions

Summary

FIVE PRIME THERAPEUTICS, INC. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $21.0MSales: $179.1M41 insiders

Date	Insider	Type	Value
2021-04-16	Civik Thomas(President and CEO)	D	$2.6M
2021-04-16	Civik Thomas(President and CEO)	D	—
2021-04-16	Lyons-Williams Lori	D	—
2021-04-16	Lyons-Williams Lori	D	—
2021-04-16	SCHAFER CAROL	D	—
2021-04-16	SCHAFER CAROL	D	—
2021-04-16	SCHAFER CAROL	D	—
2021-04-16	Nicholson Garry A	D	—
2021-04-16	Nicholson Garry A	D	—
2021-04-16	Nicholson Garry A	D	—
2021-04-16	Nicholson Garry A	D	—
2021-04-16	Jensen Peder	D	—
2021-04-16	Jensen Peder	D	—
2021-04-16	Jensen Peder	D	—
2021-04-16	Jensen Peder	D	—
2021-04-16	Jensen Peder	D	—
2021-04-16	Jensen Peder	D	—
2021-04-16	Dhingra Kapil	D	—
2021-04-16	Dhingra Kapil	D	—
2021-04-16	Dhingra Kapil	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

FIVE PRIME THERAPEUTICS, INC. — Contributions, Lobbying & Contracts | Poliscope